%A Jiazheng Li, Lei Tang %T Radiomics in Antineoplastic Agents Development: Application and Challenge in Response Evaluation %0 Journal Article %D 2021 %J Chinese Medical Sciences Journal %R 10.24920/003985 %P 187-195 %V 36 %N 3 %U {http://cmsj.cams.cn/CN/abstract/article_3372.shtml} %8 2021-09-30 %X

The recent spring up of the antineoplastic agents and the prolonged survival bring both challenge and chance to radiological practice. Radiological methods including CT, MRI and PET play an increasingly important role in evaluating the efficacy of these antineoplastic drugs. However, different antineoplastic agents potentially induce different radiological signs, making it a challenge for radiological response evaluation, which depends mainly on one-sided morphological response evaluation criteria in solid tumors (RECIST) in the status quo of clinical practice. This brings opportunities for the development of radiomics, which is promising to serve as a surrogate for response evaluations of anti-tumor treatments. In this article, we introduce the basic concepts of radiomics, review the state-of-art radiomics researches with highlights of radiomics application in predictions of molecular biomarkers, treatment response, and prognosis. We also provide in-depth analyses on major obstacles and future direction of this new technique in clinical investigations on new antineoplastic agents.